Phase 1 Cancer, Metastatic Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

Metastatic Solid TumorCancer, Metastatic

Valley Health System72 enrolled1 locationNCT05232409

Recruiting

Phase 1

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

CancerSolid Tumor, AdultCancer, Metastatic+3 more

Shenzhen Ionova Life Sciences Co., Ltd.78 enrolled3 locationsNCT04443088

Recruiting

Phase 1

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Breast Cancer MetastaticHER2-Negative Breast CarcinomaPancreatic Cancer+17 more

General Oncology, Inc.24 enrolled2 locationsNCT04150042